72 related articles for article (PubMed ID: 28179302)
1. CD24 Modulates Chemosensitivity of MCF-7 Breast Cancer Cells.
Onishi H; Suyama K; Yamasaki A; Oyama Y; Fujimura A; Kawamoto M; Imaizumi A
Anticancer Res; 2017 Feb; 37(2):561-565. PubMed ID: 28179302
[TBL] [Abstract][Full Text] [Related]
2. CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells.
Suyama K; Onishi H; Imaizumi A; Shinkai K; Umebayashi M; Kubo M; Mizuuchi Y; Oda Y; Tanaka M; Nakamura M; Katano M
Cancer Lett; 2016 Apr; 374(1):44-53. PubMed ID: 26797459
[TBL] [Abstract][Full Text] [Related]
3. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
[TBL] [Abstract][Full Text] [Related]
4. Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity.
Huber S; Wege AK; Bernhardt G; Buschauer A; Brockhoff G
Cytometry A; 2015 Aug; 87(8):707-16. PubMed ID: 25892097
[TBL] [Abstract][Full Text] [Related]
5. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
6. Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs.
Li YT; Chua MJ; Kunnath AP; Chowdhury EH
Int J Nanomedicine; 2012; 7():2473-81. PubMed ID: 22701315
[TBL] [Abstract][Full Text] [Related]
7. [Pilot study on the correlation between high incidence of CD44+/CD24 -/low/ABCG2- cells and poor prognosis in breast cancer].
Gong JF; Yuan YH; Song GH; Yu J; Han Y; Jia J; Ren J
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):465-70. PubMed ID: 18931706
[TBL] [Abstract][Full Text] [Related]
8. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
9. STAT1 promotes radioresistance of CD44(+)/CD24(-/low) cells in breast cancer.
Zhan JF; Chen LH; Yuan YW; Xie GZ; Sun AM; Liu Y; Chen ZX
Exp Biol Med (Maywood); 2011 Apr; 236(4):418-22. PubMed ID: 21444368
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of CD24 inhibits invasive growth, facilitates apoptosis and enhances chemosensitivity in gastric cancer AGS cells.
Jiao XL; Zhao C; Niu M; Chen D
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1709-15. PubMed ID: 23852892
[TBL] [Abstract][Full Text] [Related]
11. The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells.
Tanaka H; Nakamura M; Kameda C; Kubo M; Sato N; Kuroki S; Tanaka M; Katano M
Anticancer Res; 2009 Jun; 29(6):2147-57. PubMed ID: 19528475
[TBL] [Abstract][Full Text] [Related]
12. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
Nami B; Donmez H; Kocak N
Exp Toxicol Pathol; 2016 Aug; 68(7):419-26. PubMed ID: 27350212
[TBL] [Abstract][Full Text] [Related]
13. The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters.
Rigalli JP; Tocchetti GN; Arana MR; Villanueva SS; Catania VA; Theile D; Ruiz ML; Weiss J
Cancer Lett; 2016 Jun; 376(1):165-72. PubMed ID: 27033456
[TBL] [Abstract][Full Text] [Related]
14. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
15. CD24 regulates cell proliferation and transforming growth factor β-induced epithelial to mesenchymal transition through modulation of integrin β1 stability.
Lee KM; Ju JH; Jang K; Yang W; Yi JY; Noh DY; Shin I
Cell Signal; 2012 Nov; 24(11):2132-42. PubMed ID: 22800863
[TBL] [Abstract][Full Text] [Related]
16. NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells.
Zheng J; Liu Q; Li Y; Yang J; Ma J; Yu F; Shi H; Ren Q; Zhang R; Zhang J; Xue Y; Tao Y; Jiang N; Guo H; Yao L; Liu W
Asian Pac J Cancer Prev; 2010; 11(6):1817-21. PubMed ID: 21338239
[TBL] [Abstract][Full Text] [Related]
17. Smoothened activates breast cancer stem-like cell and promotes tumorigenesis and metastasis of breast cancer.
Wang L; Duan W; Kang L; Mao J; Yu X; Fan S; Li L; Tao Y
Biomed Pharmacother; 2014 Oct; 68(8):1099-104. PubMed ID: 25451166
[TBL] [Abstract][Full Text] [Related]
18. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
19. Characteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature.
Tsunoda Y; Sakamoto M; Sawada T; Sasaki A; Yamamoto G; Tachikawa T
Oncology; 2011; 81(5-6):336-44. PubMed ID: 22237177
[TBL] [Abstract][Full Text] [Related]
20. Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7.
Kim HJ; Kim JB; Lee KM; Shin I; Han W; Ko E; Bae JY; Noh DY
Cancer Lett; 2007 Dec; 258(1):98-108. PubMed ID: 17950993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]